LOGIN
Zoledronic acid: best overall bisphosphonate treatment for osteoporosis fractures
March 2014
Zoledronic acid: best overall bisphosphonate treatment for osteoporosis fractures
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A
The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-nonhip fractures in osteoporosis: a network meta-analysis
Semin Arthritis Rheum. 2011 Feb;40(4):275-84.e1-2.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
8 randomized placebo controlled trials (including over 20,000 patients) that investigated the effects of different bisphosphonate treatments for osteogenesis in postmenopausal women were evaluated with the aim of determining a superior treatment. A network meta-analysis using the Bayesian approach was conducted to analyze the indirect comparisons provided in the study and found that zoledronic aci...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.